期刊文献+

甲状腺微小髓样癌8例临床病理分析 被引量:4

Thyroid micromedullary carcinoma: clinicopathologic study of 8 cases
下载PDF
导出
摘要 目的探讨甲状腺微小髓样癌的临床病理特征、诊断及治疗。方法收集8例甲状腺微小髓样癌,分析其临床病理学特征并复习相关文献。结果甲状腺微小髓样癌病灶小,癌细胞起源于甲状腺滤泡旁C细胞,间质丰富,癌细胞具有多形性,核仁不清晰,核分裂象较少见,被纤维血管和(或)淀粉样物分隔。免疫组化标记Calcitonin(+)可作为诊断指标。结论甲状腺微小髓样癌的术后组织病理检查是明确诊断的金标准,甲状腺全切术配合中央区及侧区淋巴结清扫是当前患者的最优治疗方案。 Purpose To investigate the characteristics,pathological features,diagnosis and treatment of thyroid micromedullary carcinoma.Methods Eight cases of thyroid micromedullary carcinoma were collected.The pathological and diagnostic features were analyzed.Results The focus of thyroid micromedullary carcinoma were small.The cancer cells originated from the parafollicular C cells.The interstitial cells were abundant,the cancer cells were pleomorphic,the nucleolus was not clear,the nuclear mitosis was rare,separated by fibrovascular and/or amyloid stroma.Immunohistochemical marker of Calcitonin(+)could be used as a diagnostic marker.Conclusion The postoperative histopathological examnintaion of thyroid micromedullary carcinoma is the gold standard for its definite diagnosis.Total thyroidectomy with central and lateral lymph node dissection is the best treatment for the patients.
作者 薛松 王浩 蔡兆根 吴正升 XUE Song;WANG Hao;CAI Zhao-gen;WU Zheng-sheng(3Department of Clinical Pathology,the First Affiliated Hospital of Bengbu Medical College/Department of Pathology,Bengbu Medical College,Bengbu 233003,China;Department of Pathology,Anhui Medical University,Hefei 230032,China)
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2019年第7期795-798,共4页 Chinese Journal of Clinical and Experimental Pathology
关键词 甲状腺肿瘤 微小髓样癌 降钙素 病理诊断 thyroid neoplasm micromedullary carcinoma Calcitonin pathology diagnosis
  • 相关文献

参考文献9

二级参考文献42

  • 1李树玲,杨力珍.甲状腺髓样癌[J].普外临床,1989,4(1):52-55. 被引量:11
  • 2江昌新,谭郁彬,李恩鸿.甲状腺髓样癌的组织病理学和免疫组织化学的研究[J].中华病理学杂志,1996,25(6):332-335. 被引量:5
  • 3Brunt LM,Wells SA. Advances in the diagnosis and treatment of medullary thyroid carcinoma[J]. J Surg Clin North Am,1987,67(2):263-279.
  • 4Hofstra RM,Landsvater RM,Ceccherini I,et al. A mutation in the RET protooncogene associated with MEN2B and sporadic medullary carcinoma[J].Nature 1994;367(6461):375-376.
  • 5Sternberg SS. 诊断外科病理学[M]. 第3版. 回允中译. 北京:北京大学出版社 ,2003.549.
  • 6Saad MF,Fritsche HA Jr,Samaan NA. Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid[J]. J Clin Endocrinol Metab,1984,58(5):889-894.
  • 7Engelbach M,Gorges R, Forst T et al.  Improved diagnostic methods in the follow-up of medullary thyroid carcinoma by highly specific calcitonin measurements[J]. J Clin Endocrinol Metab, 2000, 85(5):1890-1894.
  • 8Takami H, Bessho T, Kameya T,et al. Immunohistochemical study of medullary thyroid carcinoma :relationship of clinical features to prognostic factors in 36 patients[J]. World J Surg,1988,12(4):572-579.
  • 9Wang C, Lin J, Li L, et al. Expression and clinical significance of girdin in gastric cancer[ J ]. Mol Clin Oncol, 2014,2 (3) :425 - 8.
  • 10Enomoto A, Murakami H, Asai N, et al. Akt/PKB regulates actin organization and cell motility via Girdin/APE [ J ]. Dev Cell, 2005,9(3) :389 -402.

共引文献21

同被引文献25

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部